Free shipping on all orders over $ 500

Cendakimab

Cat. No. M24956

All AbMole products are for research use only, cannot be used for human consumption.

Cendakimab Structure
Synonym:

RPC 4046; ABT 308; CC-93538

Size Price Availability Quantity
100ug USD 160 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Cendakimab (RPC4046; ABT 308; CC-93538) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both IL-13Rα1 and IL-13Rα2 with IC50s of 352 pM and 631 pM by ELISA, respectively. Cendakimab recognizes both wild-type human IL-13 and the common polymorphic variant R110Q, with binding affinities of 52 and 50 pM, respectively. Cendakimab has the potential for IL-13-related allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis).

Chemical Information
CAS Number 2151032-62-9
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Alfredo J Lucendo, et al. BioDrugs. Targeted Therapies for Eosinophilic Gastrointestinal Disorders

[2] Alfredo J Lucendo. Expert Opin Pharmacother. Drυg treatment strategies for eosinophilic esophagitis in adults

[3] Evan S Dellon, et al. Ann Allergy Asthma Immunol. Biologics in eosinophilic gastrointestinal diseases

[4] Sonsoles Tamarit-Sebastian, et al. Expert Opin Investig Drugs. Current options and investigational drυgs for the treatment of eosinophilic esophagitis

Related IL Receptor/Related Products
Reslizumab

Reslizumab (Sch 55700) is a humanized monoclonal antibody targeting human interleukin 5 (IL-5) for the study of eosinophilic asthma. Reslizumab effectively blocks il-5 function. Reslizumab inhibited IL-5-dependent cell proliferation with an IC50 of about 91.1 pM.

Montelukast sodium

Montelukast sodium selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1.

VGX-1027

VGX-1027 is an orally active immunomodulator.

Diacerein

Diacerin is an inhibitor of pro-inflammatory cytokine Interleukin-1B (IL-1B) production, prescribed for osteoarthritis and chronic inflammatory arthritis.

SC144

SC144 is the first oral active GP130 (IL6-beta) inhibitor. SC144 binds gp130, induces gp130 phosphorylation (S782) and deglycosylation, eliminates Stat3 phosphorylation and nuclear translocation, and further inhibits downstream target gene expression. SC144 inhibited signal transduction induced by GP130 ligand. SC144 induces apoptosis of human ovarian cancer cells.

  Catalog
Abmole Inhibitor Catalog




Keywords: Cendakimab, RPC 4046; ABT 308; CC-93538 supplier, IL Receptor/Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.